193 related articles for article (PubMed ID: 25959850)
1. Exposure-effect relationship of mycophenolic acid and prednisolone in adult patients with lupus nephritis.
Abd Rahman AN; Tett SE; Abdul Gafor HA; McWhinney BC; Staatz CE
Br J Clin Pharmacol; 2015 Nov; 80(5):1064-75. PubMed ID: 25959850
[TBL] [Abstract][Full Text] [Related]
2. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of concentration-controlled mycophenolate mofetil in proliferative lupus nephritis: an observational cohort study.
Alexander S; Fleming DH; Mathew BS; Varughese S; Jeyaseelan V; Tamilarasi V; Jacob CK; John GT
Ther Drug Monit; 2014 Aug; 36(4):423-32. PubMed ID: 25014074
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic drug monitoring of mycophenolate mofetil for the treatment of severely active lupus nephritis.
Kittanamongkolchai W; Rukrung C; Supasiri T; Lertjirachai I; Somparn P; Chariyavilaskul P; Avihingsanon Y
Lupus; 2013 Jun; 22(7):727-32. PubMed ID: 23651860
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of free and total mycophenolic acid in adult lupus nephritis patients-implications for therapeutic drug monitoring.
Łuszczyńska P; Pawiński T; Kunicki PK; Durlik M; Augustyniak-Bartosik H; Hurkacz M
Eur J Clin Pharmacol; 2019 Mar; 75(3):371-379. PubMed ID: 30430214
[TBL] [Abstract][Full Text] [Related]
6. Kidney transplant outcomes are related to tacrolimus, mycophenolic acid and prednisolone exposure in the first week.
Barraclough KA; Staatz CE; Johnson DW; Lee KJ; McWhinney BC; Ungerer JP; Hawley CM; Campbell SB; Leary DR; Isbel NM
Transpl Int; 2012 Nov; 25(11):1182-93. PubMed ID: 22946513
[TBL] [Abstract][Full Text] [Related]
7. Comparison of pharmacokinetics of mycophenolic acid and its glucuronide between patients with lupus nephritis and with kidney transplantation.
Mino Y; Naito T; Matsushita T; Otsuka A; Ushiyama T; Ozono S; Hishida A; Kagawa Y; Kawakami J
Ther Drug Monit; 2008 Dec; 30(6):656-61. PubMed ID: 18978521
[TBL] [Abstract][Full Text] [Related]
8. Concentration-controlled treatment of lupus nephritis with mycophenolate mofetil.
Daleboudt GM; Reinders ME; den Hartigh J; Huizinga TW; Rabelink AJ; de Fijter JW; Berger SP
Lupus; 2013 Feb; 22(2):171-9. PubMed ID: 23257398
[TBL] [Abstract][Full Text] [Related]
9. Development of Improved Dosing Regimens for Mycophenolate Mofetil Based on Population Pharmacokinetic Analyses in Adults with Lupus Nephritis.
Abd Rahman AN; Tett SE; Abdul Gafor HA; McWhinney BC; Staatz CE
Eur J Drug Metab Pharmacokinet; 2017 Dec; 42(6):993-1004. PubMed ID: 28536776
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic drug monitoring of mycophenolic acid and clinical outcomes of lupus nephritis: a systematic review and meta-analysis.
Wuttiputhanun T; Naiyarakseree N; Udomkarnjananun S; Kittanamongkolchai W; Asada L; Chariyavilaskul P; Townamchai N; Avihingsanon Y
Lupus Sci Med; 2024 Jan; 11(1):. PubMed ID: 38233072
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and pharmacogenomics of mycophenolic acid and its clinical correlations in maintenance immunosuppression for lupus nephritis.
Yap DYH; Tam CH; Yung S; Wong S; Tang CSO; Mok TMY; Yuen CKY; Ma MKM; Lau CS; Chan TM
Nephrol Dial Transplant; 2020 May; 35(5):810-818. PubMed ID: 30215770
[TBL] [Abstract][Full Text] [Related]
12. Clinical pharmacokinetics and pharmacodynamics of mycophenolate in patients with autoimmune disease.
Abd Rahman AN; Tett SE; Staatz CE
Clin Pharmacokinet; 2013 May; 52(5):303-31. PubMed ID: 23475567
[TBL] [Abstract][Full Text] [Related]
13. Mycophenolic mofetil optimized pharmacokinetic modelling, and exposure-effect associations in adult heart transplant recipients.
Woillard JB; Saint-Marcoux F; Monchaud C; Youdarène R; Pouche L; Marquet P
Pharmacol Res; 2015 Sep; 99():308-15. PubMed ID: 26192348
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic Drug Monitoring of Mycophenolic Acid in Lupus Nephritis: A Review of Current Literature.
Łuszczyńska P; Pawiński T
Ther Drug Monit; 2015 Dec; 37(6):711-7. PubMed ID: 26034895
[TBL] [Abstract][Full Text] [Related]
15. Comparison of mycophenolic acid pharmacokinetic parameters in kidney transplant patients within the first 3 months post-transplant.
Pawinski T; Durlik M; Szlaska I; Urbanowicz A; Majchrnak J; Gralak B
J Clin Pharm Ther; 2006 Feb; 31(1):27-34. PubMed ID: 16476117
[TBL] [Abstract][Full Text] [Related]
16. How delayed graft function impacts exposure to mycophenolic acid in patients after renal transplantation.
van Gelder T; Silva HT; de Fijter H; Budde K; Kuypers D; Mamelok RD; Armstrong VW; Oellerich M
Ther Drug Monit; 2011 Apr; 33(2):155-64. PubMed ID: 21383657
[TBL] [Abstract][Full Text] [Related]
17. Best single time points as surrogates to the tacrolimus and mycophenolic acid area under the curve in adult liver transplant patients beyond 12 months of transplantation.
Mardigyan V; Tchervenkov J; Metrakos P; Barkun J; Deschenes M; Cantarovich M
Clin Ther; 2005 Apr; 27(4):463-9. PubMed ID: 15922819
[TBL] [Abstract][Full Text] [Related]
18. To TDM or not to TDM in lupus nephritis patients treated with MMF?
van Gelder T; Berden JH; Berger SP
Nephrol Dial Transplant; 2015 Apr; 30(4):560-4. PubMed ID: 24811231
[TBL] [Abstract][Full Text] [Related]
19. Population pharmacokinetics of mycophenolate mofetil in Thai lupus nephritis patients.
Punyawudho B; Lertdumrongluk P; Somparn P; Kittanamongkolchai W; Traitanon O; Avihingsanon Y; Vadcharavivad S
Int J Clin Pharmacol Ther; 2012 Apr; 50(4):272-80. PubMed ID: 22456298
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of multi-target therapy using a combination of tacrolimus, mycophenolate mofetil and a steroid in patients with active lupus nephritis.
Ikeuchi H; Hiromura K; Takahashi S; Mishima K; Sakurai N; Sakairi T; Kaneko Y; Maeshima A; Kuroiwa T; Nojima Y
Mod Rheumatol; 2014 Jul; 24(4):618-25. PubMed ID: 24252014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
